Table 1.
Clinical and Demographic Characteristics
| CM, HIV− (N=40) | CM, HIV+ (N=40) | TW, HIV− (N=47) | TW, HIV+* (N=75) | |
|---|---|---|---|---|
| Age | 43 (35, 52) | 48 (43, 54) | 40 (32, 48) | 43 (37, 52) |
| Black race | 13% | 23% | 13% | 27% |
| Hispanic ethnicity | 65% | 60% | 64% | 57% |
| Overweight/obese (BMI >25 kg/m2) | 58% | 67% | 30% | 24% |
| Former smoker | 60% | 58% | 22% | 11% |
| Current smoker | 20% | 28% | 28% | 37% |
| Recreational drug use | 28% | 48% | 23% | 41% |
| >=14 drinks/week | 5% | 3% | 11% | 8% |
| Hypertension | 40% | 39% | 17% | 33% |
| Diabetes mellitus | 13% | 19% | 15% | 13% |
| INSTI-based | 13% | 49% | ||
| CD4+ T lymphocyte count (cells/μL) | 650 (466,846) | 580 (391,841) | ||
| CD4+ T lymphocyte nadir <200 (cells/μL) | 48% | 54% | ||
| Detectable HIV-1 RNA (≥50 copies/ml) | 0% | 32% | ||
| Any AIDS diagnosis | 8% | 36% | ||
| Feminizing Hormonal Therapy | 66% | 68% |
Frequency or median (interquartile range) presented.
*
When restricting to TW with undetectable HIV-1 RNA, age, current smoking and high-risk alcohol use frequency more closely resembled CM. TW=transgender women, CM=cisgender males, NNRTI= non-nucleoside reverse transcriptase inhibitors, PI=protease inhibitors, INTI=integrase strand transfer inhibitors